Clinical Study of Tolterodine Tartrate in the Treatment of Overactive Bladder

Objective To explore the clinical therapeutic effect and safety of Tolterodine Tartrate in the treatment of overactive bladder(OAB).Methods Sixty patients with OAB were randomly divided into experimental group(n=30)orally administrated one tablet of Tolterodine Tartrate(2mg/tablet)and control group(n=30)orally given Finasteride,5mg,QD;Tan solo sustained-release capsules,0.2g,QD,42das one course.Urination and OABSS were recorded and Qmax were examined before and after treatment.Results The frequencies of urination,urgent urination,nocturia and urge incontinence in experimental group decreased obviously with increased voided volume each time,compared with the treatment before and with those in control group.Additionally,the OABSS and adverse reaction were evidently lower in experimental group after treatment than those in control group.Conclusion Tolterodine Tartrate is an ideal medicine in treating OAB.